Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection. - Wikidata - wikimedia - TriplyDB

Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection.

Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection.

http://www.wikidata.org/entity/Q36874661

about

Dynamics of HCV RNA levels during acute hepatitis C virus infection.Association of interferon-gamma induced protein 10 promoter polymorphisms with the disease progression of hepatitis B virus infection in Chinese Han population Plasma interferon-gamma-inducible protein-10 levels are associated with early, but not sustained virological response during treatment of acute or early chronic HCV infection Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection.Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection.Associations of Self-Reported Sleep Quality with Circulating Interferon Gamma-Inducible Protein 10, Interleukin 6, and High-Sensitivity C-Reactive Protein in Healthy Menopausal Women.Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients.Comparative Analysis of Liver Injury-Associated Cytokines in Acute Hepatitis A and B.Plasma interferon-gamma-inducible protein 10 can be used to predict viral load in HIV-1-infected individuals.HIV and co-infections.B-Cell Activating Factor Belonging to the Tumor Necrosis Factor Family and Interferon-γ-Inducible Protein-10 in Autoimmune Hepatitis.Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection.Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users.Predictive Value of Serum IFN-γ inducible Protein-10 and IFN-γ/IL-4 Ratio for Liver Fibrosis Progression in CHB Patients.Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men.Acute hepatitis C: management in the rapidly evolving world of HCV.Cross-genotype-specific T-cell responses in acute hepatitis E virus (HEV) infection.HCV avidity as a tool for detection of recent HCV infection: sensitivity depends on HCV genotype.Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection.Toll-like Receptor Expression and Signaling in Peripheral Blood Mononuclear Cells Correlate With Clinical Outcomes in Acute Hepatitis C Virus Infection.Adiponectin attenuates liver fibrosis by inducing nitric oxide production of hepatic stellate cells.Interleukin-28B polymorphisms and interferon gamma inducible protein-10 serum levels in seronegative occult hepatitis C virus infection.Association of interferon-γ-induced protein-10 serum levels with virological responses to PEG-interferon-based therapy in hepatitis C virus genotype 1 or 2 chronically infected Chinese patients.Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection.Interferon-lambda polymorphisms and hepatitis C virus clearance revisited.Clinical significance of pretreatment serum interferon-gamma-inducible protein 10 concentrations in chronic hepatitis C patients treated with telaprevir-based triple therapy.Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance

P2860

Q34771346-413CB38B-B1E5-44BF-BE91-1E36FADD92B2 Q34984063-F00AFB9B-1012-490C-9D60-9BFCCC745A3E Q35053399-5F9AA43A-74EA-44C6-90CB-D74882CD056E Q35764450-F239A9F3-4C16-45AA-B886-8F0EC0A7B417 Q36014286-C3022A6C-0CA3-48F2-A518-A882EA4EF4C1 Q36035679-01837221-C431-4826-B1DE-364372F7A24E Q36242827-29ABC010-4825-4F5B-8FA0-223B818E888E Q36611680-4EC2545F-9818-4935-A5FA-E0F5FD926A1E Q36628383-2A52F3B3-9E03-495F-91E6-691C77C83468 Q36707912-4398F79F-84D3-4CE0-8E49-AF9FD7D4DADB Q36929674-2B1163E2-D92D-4831-9D0F-EAD2E73B5E4F Q36970184-610E9085-0FE9-47E9-9E74-DFC915E591E3 Q37205477-C25539C3-ACF4-427E-8C8F-31C68442814F Q37285273-B7C18A32-36EC-439F-B008-470907EB33AB Q37540482-5C4B7D7A-8177-4D82-9965-BF3E5ABBFF1C Q37571093-AF2E5351-8FB9-43D3-8C29-32C6FA774FF7 Q37604517-687ABE10-5178-438C-B39D-440D0C9EDFB3 Q38183312-5846CFD2-1034-4366-A2A3-8BA970996BF0 Q39024688-3B82EC67-6757-4C47-A3F6-C257A4830A85 Q40069643-594DB01A-0D59-4331-81BC-74904AD18546 Q40659995-B397DF80-3551-4E9A-9816-591BCFF14344 Q40708778-96599EA9-926B-4C5C-B09C-F6CA69561F04 Q40759563-B11769A4-F717-4F84-BC5C-20A9849F87C7 Q41120919-2C078B93-A762-4B9E-8BF4-23DF60AE5EF9 Q41723912-AFA537AD-9C0E-4E48-8C12-04960AEE9550 Q42229061-5B3EE5FB-5B1C-4873-9660-76494AF9A67D Q45351788-1BAC3829-48F2-4123-9825-4021483866EF Q48015504-3AE4A2ED-FA46-4C78-A164-431D5D55F64F Q58730590-7E0F2344-F234-4B1A-83BD-EAC2A15E1885

P2860

Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection.

http://www.wikidata.org/entity/Q36874661

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Plasma interferon-gamma-induci ...... e hepatitis C virus infection.

@en

type

label

Plasma interferon-gamma-induci ...... e hepatitis C virus infection.

@en

prefLabel

Plasma interferon-gamma-induci ...... e hepatitis C virus infection.

@en

P1433

Q36874661-F7FE7254-0E6D-4259-9337-7D26515DED2D

P1476

Q36874661-995C2882-1616-452E-B41F-30445E02C596

P2093

Q36874661-15C41810-8E3E-477E-A459-42FBF03B6EE3

Q36874661-31EC39EF-9CA2-43B5-B3E6-A010E807A8C4

Q36874661-41D7F51B-BB12-4527-94D3-C74D42786DFC

Q36874661-47208CF1-3F9C-4C0A-9CF9-6C8C1AF72490

Q36874661-48547A78-B11E-400F-A165-E2D030CEE66C

Q36874661-4C5C2B14-67FF-447D-BB01-7DA8A3CC1783

Q36874661-61AA1E66-DF79-4143-BF23-AB0E9A3F0D2A

Q36874661-66D4A330-BEC8-4F99-A0C4-F246D1CC32D2

Q36874661-6E15864F-5A14-41DA-879B-D141C113EE30

Q36874661-777D3874-513B-428E-AD07-AA8C7DEB3BC4

P2860

Q36874661-01160CAC-59EA-4835-8641-A13D4C1DF808

Q36874661-03C261A3-4AEC-4690-B0A9-62ED16EE11C1

Q36874661-04AEEF48-5E92-4D60-BFDE-28B2B426CFC2

Q36874661-11659CB3-55B1-4BB4-97C6-37DE7E5D8719

Q36874661-1BAF06C5-B52E-4FA7-B077-2326965945BF

Q36874661-2546D1D1-2A87-49FD-A490-09FAAF86CA65

Q36874661-29E69E17-5A86-4144-B5C1-A37075B893BF

Q36874661-3040AE0D-262B-4163-8140-0023833153F6

Q36874661-3A04FAE2-C18D-4CF0-BF7F-8A13EC614165

Q36874661-42AECBC5-809B-4853-893D-C35E06466DB2

P304

Q36874661-D1B3D329-5D0B-4858-9191-8ED90B7B747B

P31

Q36874661-B5802775-1E76-4A15-85AA-01A0F9B04B9F

P356

Q36874661-E59F47FB-37F2-4AC7-913A-442454E1AB26

P407

Q36874661-E21862E9-2EA6-4C27-B880-03AACC11EBCC

P433

Q36874661-99DA2C13-EB26-4925-B854-FFB6E809DD5E

P478

Q36874661-7F1F0AD4-39B5-4C8F-901E-9E318DD67ECF

P50

Q36874661-30A36344-0903-463B-AC9D-A62995D2CD4B

Q36874661-D68E09BC-CA53-4394-8AC6-B484A4FE78E5

P577

Q36874661-A9CA2334-E2DB-4D53-B111-C9D50F6C1550

P5875

Q36874661-B7895C43-F380-4791-A140-13F9CB185836

P698

Q36874661-3BDD1D1A-E517-4B57-B8E2-FCF9FD123CE6

P932

Q36874661-C1951A68-32BC-4BEE-AEB5-F038D9CA7372

P356

P1433

P1476

Plasma interferon-gamma-induci ...... te hepatitis C virus infection

@en

P2093

Alana Sherker

http://www.w3.org/2001/XMLSchema#string

Barbara Yeung

http://www.w3.org/2001/XMLSchema#string

Gail V Matthews

http://www.w3.org/2001/XMLSchema#string

Geng Zang

http://www.w3.org/2001/XMLSchema#string

Gregory J Dore

http://www.w3.org/2001/XMLSchema#string

Ineke Shaw

http://www.w3.org/2001/XMLSchema#string

Jacob George

http://www.w3.org/2001/XMLSchema#string

Jason Grebely

http://www.w3.org/2001/XMLSchema#string

John M Kaldor

http://www.w3.org/2001/XMLSchema#string

Jordan J Feld

http://www.w3.org/2001/XMLSchema#string

P2860

Interferon signaling and treatment outcome in chronic hepatitis C

Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users

Improving the Diagnosis of Acute Hepatitis C Virus Infection with Expanded Viral Load Criteria

Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV

Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response.

Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort

P304

2124-2134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.26263

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Andrew R. Lloyd

Tanya Applegate

P577

2013-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234158165

http://www.w3.org/2001/XMLSchema#string

P698

23325615

http://www.w3.org/2001/XMLSchema#string

P932

3663887

http://www.w3.org/2001/XMLSchema#string